Net Cash Provided by (Used in) Financing Activities of NEOGENOMICS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NEOGENOMICS INC annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NEOGENOMICS INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $949,000, a 16% increase year-over-year.
  • NEOGENOMICS INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $200,288,000, a 4411% decline from 2024.
  • NEOGENOMICS INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4,646,000, a 2% increase from 2023.
  • NEOGENOMICS INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,554,000, a 62% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

NEOGENOMICS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $200,288,000 -$204,934,000 -4411% 01 Jan 2025 31 Dec 2025 10-K 17 Feb 2026 2025 FY
2024 $4,646,000 +$92,000 +2% 01 Jan 2024 31 Dec 2024 10-K 17 Feb 2026 2025 FY
2023 $4,554,000 -$7,275,000 -62% 01 Jan 2023 31 Dec 2023 10-K 17 Feb 2026 2025 FY
2022 $11,829,000 -$713,456,000 -98% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
2021 $725,285,000 +$489,688,000 +208% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $235,597,000 +$76,131,000 +48% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
2019 $159,466,000 +$67,507,000 +73% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $91,959,000 +$96,054,000 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $4,095,000 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2013 $2,750,000 -$634,000 -19% 01 Jan 2013 31 Dec 2013 10-K 24 Feb 2014 2013 FY
2012 $3,384,000 +$1,025,000 +43% 01 Jan 2012 31 Dec 2012 10-K 24 Feb 2014 2013 FY
2011 $2,359,000 -$75,000 -3.1% 01 Jan 2011 31 Dec 2011 10-K 24 Feb 2014 2013 FY
2010 $2,434,000 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2012 2011 FY

NEOGENOMICS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $949,000 +$133,000 +16% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025 2025 Q1
Q1 2024 $816,000 -$563,000 -41% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025 2025 Q1
Q1 2023 $1,379,000 -$4,678,000 -77% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024 2024 Q1
Q1 2022 $6,057,000 -$518,878,000 -99% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $524,935,000 +$524,318,000 +84979% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $617,000 +$134,000 +28% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $483,000 +$7,732,000 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
Q1 2018 $7,249,000 -$10,453,000 -326% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $3,204,000 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2013 $4,329,000 +$1,822,000 +73% 01 Jan 2013 31 Mar 2013 10-Q 13 May 2013 2013 Q1
Q1 2012 $2,507,000 -$544,000 -18% 01 Jan 2012 31 Mar 2012 10-Q 13 May 2013 2013 Q1
Q1 2011 $3,051,000 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.